Results 13,101-13,120 of 26,396 for speaker:David Cullinane

Public Accounts Committee: Business of Committee (22 Nov 2018)

David Cullinane: Okay.

Public Accounts Committee: Business of Committee (22 Nov 2018)

David Cullinane: I would like to follow up on that. When we looked at Project Eagle, we found that many issues arose with deviations from sales practices and the management of conflicts of interest, etc. It would be a bit naive of us to think that such issues did not arise in other loan sales. We are now getting information on a significant loan sale. If it is the case that the Comptroller and Auditor...

Public Accounts Committee: Business of Committee (22 Nov 2018)

David Cullinane: Everyone could have a vote.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: Go raibh maith agat a Chathaorligh. May I start by stating that the Committee of Public Accounts is not a court, there are no kangaroos here so Mr. Breslin and Mr. Connaghan can rest easy? How many cases are outstanding to be heard by the Hepatitis C Compensation Tribunal?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: Would it be fair to say that in most of the remaining cases, the adults would have been infected when they were children? Of the profile of the 455 individuals, would it be fair to say that most of these adults were infected when they were children?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: Would they be mostly young men?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: Would Ms Tait know?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: At this point, may I commend Dr. Brian O'Mahony, the chief executive of the Irish Haemophilia Society? I know he has worked with Mr. Breslin and the HSE. The Irish Haemophilia Society has done major work for the people who suffered as a consequence of this medical negligence scandal. I spoke to a number of people who have been through the process and have been compensated, which is the...

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: I thank Mr. Breslin. His response is appreciated. I will now deal with the report of the Comptroller and Auditor General, which is primarily why we are here. The insurance scheme is referenced in page 165 and the report notes that the HSE does not have a current estimate of future expenditure to be incurred on the scheme. Why is there no estimate?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: May I interrupt Ms Tait? The Comptroller and Auditor General referred to this in his report. Is he simply noting that there is no current estimate of the cost or is he saying that is a difficulty?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: There was no learning from the figure being unavailable. Was Mr. McCarthy noting that there was no estimated cost?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: The report of the Comptroller and Auditor General states that in 2012 the HSE estimates that between 20,000 and 30,000 people were infected by hepatitis C with around 10,000 individuals living with chronic infection at the end of 2009. Those figures were from nine years ago. Does the HSE have up-to-date figures? Are the figures much the same or have they changed?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: Professor McCormick mentioned the modelling study. Was that Europe-wide?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: It estimated that 29,500 people were affected.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: No. I am referring to the modelling study. I am looking on page 167 of the-----

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: Therefore, there were two modelling studies.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: Professor McCormick might be able to help me with this. Paragraph 15.26 on page 167 of the Comptroller and Auditor General's report states, "A modelling study in hepatitis C prevalence in 2015 carried out for 28 EU countries estimated the number infected with the hepatitis C virus in Ireland at 29,500."

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: How did the modelling study work? Is that an estimate?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: Reference to under-diagnosis and the national screening guideline for hepatitis C is made on page 168 of the Comptroller and Auditor General report. It stated that no national guidance for healthcare providers was developed. Is that still the case?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

David Cullinane: The Comptroller and Auditor General might be able to help me with what is meant. Paragraph 15.29 states:With regard to reducing under-diagnosis, the HSE in collaboration with the Department of Health published the National Screening Guideline for Hepatitis Cin 2017. The guidelines acknowledged that while screening for hepatitis C had been ongoing in many settings, national guidance for...